Hepatitis B vaccine recombinant (Evans Vaccines)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameHepatitis B vaccine recombinant (Evans Vaccines)
Drug Alias NameHepageneHepacare
ClassificationVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Genetically engineered subunit vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsHepatitis B
Global Approved IndicationsHepatitis B
Approved Indications in ChinaN/A
Original Approved Country/TerritoryEU
Original Approved Date2000/08/04
Country/TerritoryEU
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesEpitec
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEvans Vaccines Ltd
Active IndicationsN/A
Inactive IndicationsHepatitis B

Other Information

ATC CodeJ07BC01
Related LinksN/A